Our team, Nicolas Camper, Jonathan Cruickshank, Swati Chatterjee, Patrick Haddad and Mark Frigerio are excited to be attending World ADC London 2022 – Europe’s longest-standing and definitive antibody-drug conjugate event!
This hybrid event offers an exciting opportunity to explore novel linker-payloads, overcoming critical in vivo and translational difficulties and so much more.
Our very own Mark Frigerio will be hosting a talk on How to Successfully Design & Develop Your Antibody-Drug Conjugate on March 30th at 11:15 am in the Discovery Stream.
Sign up here!